AlphAIAlphAI — Financial news for AI agents
finance.yahoo.comOCT 62 min read$NEOG

What Neogen (NEOG) Said on Its Q1 Earnings Call

Neogen (NEOG) reported Q1 adjusted EBITDA of $41.6M, up 170 bps YoY. Adjusted net income was $17.5M, EPS $0.08. Free cash flow improved by $18M. Debt stood at $774M, cash at $172M. The company raised fiscal 2027 revenue guidance to $885M-$890M and adjusted EBITDA to $181M-$183M. It expects margin improvements post-Petrifilm transition and announced a collaboration with Hinalea. The genomics sale is under regulatory review, with proceeds earmarked for debt reduction.

Original reporting
finance.yahoo.com
Published Oct 6, 2026, 11:02 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 11:05 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
What Neogen (NEOG) Said on Its Q1 Earnings Call — source image
Source · finance.yahoo.com
Decision brief

The 30-second read

$NEOGBullishMed
01

Why it matters

The earnings beat and guidance raise provide a fresh catalyst for price movement, especially in after-hours trading.

02

Market read

Earnings beat and guidance lift make NEOG a near-term trading candidate.

03

What to watch

Regulatory review of genomics sale could delay cash proceeds, adding downside risk.

Relevance 8/10Novelty 8/10Timing: after-hours

Background

Neogen reported Q1 results, highlighted margin expansion, cash flow improvement, and raised FY2027 revenue guidance while noting pending genomics divestiture review.

Company-level read

Ticker impact

$NEOGBullishHigh confidence
Context

Q1 earnings release with adjusted EBITDA $41.6M, free cash flow $4.7M, and raised FY2027 revenue guidance to $885-$890M.

Expected impact

likely upward pressure as market prices in higher revenue and EBITDA guidance

Evidence & confidence

Earnings beat on cash flow and margin expansion, plus guidance lift, are fresh primary information.

Market effects

Sector

Food safety sector may see broader optimism from Neogen's guidance lift.

Regional

U.S. small-cap biotech/diagnostics segment could benefit.

Global

Limited to companies with similar product lines.

Counterpoint

What could challenge this read

Guidance may be modest relative to peers; investors could wait for Q2 results.

Key entities

  • Company
    Neogen Corporation

    NASDAQ-listed provider of food safety and animal safety products.

Read at source← All news

Also covered by

1 outlet

Related articles

OCT 6
$NEOGMedAI 8/10

Compared to Estimates, Neogen (NEOG) Q1 Earnings: A Look at Key Metrics

Neogen (NEOG) reported Q1 revenues across various segments, generally meeting or exceeding estimates. Food Safety revenues grew 7.3% YoY to $163.2M, while Animal Safety revenues increased 4.3% YoY to $59.6M. Some segments saw significant changes, such as Animal Safety Genomics Services, up 211.4% YoY, and Food Safety Genomics Services, down 59.6% YoY.

finance.yahoo.com2 min
OCT 6
$NEOGMed

Neogen’s (NASDAQ:NEOG) Q3 CY2026: Strong Sales, Stock Soars

Neogen (NEOG) reported Q3 CY2026 revenue of $222.8M, beating estimates by 7% and growing 6.5% YoY. Adjusted EPS of $0.08 beat estimates by 50%. The company raised full-year revenue guidance to $887.5M and EBITDA guidance to $182M, both above analyst estimates. Operating margin improved to -0.8% from -7.7% YoY, and free cash flow turned positive at $4.7M.

finance.yahoo.com2 min
OCT 6
$PENGHighAI 8/10

After-Hours Movers: PENG, STZ, NEOG

Penguin Solutions (PENG) rose 3% after reporting strong Q4 results and upbeat FY2027 guidance. Constellation Brands (STZ) fell 5% despite Q2 beat, citing lower FY2027 EPS guidance. Neogen (NEOG) surged 8% on Q1 beat and raised FY2027 revenue outlook. PENG: $1.00 adj. EPS, $567M revenue; STZ: $3.74 EPS, $2.63B revenue; NEOG: $0.08 EPS, $222.8M revenue.

investing.com2 min
OCT 6
$NEOGHighAI 8/10

Neogen: Fiscal Q1 Earnings Snapshot

Neogen Corp. (NEOG) reported a fiscal Q1 loss of $11.9 million, or 5 cents per share, but adjusted earnings of 8 cents per share, beating analyst estimates. Revenue was $222.8 million, exceeding expectations. The company forecasts full-year revenue between $885M and $890M.

finance.yahoo.com2 min